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1. Introduction 
The use of some drugs would be greatly improved 
by concentrating them in those cells where their 
pharmacological action is required. This might be 
obtained by conjugating the drug to amacromolecular 
vector which is selectively taken up by target cells. If 
the bond between the drug and the carrier is broken 
down in lysosomes, the drug should be released free 
and concentrated into the cells where it was trans- 
ported by the carrier [ 1,2]. When inhibitors of DNA 
synthesis are employed as antiviral agents, their con- 
centration in infected cells would allow a more eff- 
cient inhibition of virus replication accompanied by 
a lower toxicity for tissues containing proliferating 
cells, such as bone marrow and gut. In previous 
experiments wo inhibitors of DNA synthesis, cyto- 
sine arabinoside and Wluorodeoxyuridine, were 
concentrated in liver Kupffer cells of mice by con- 
jugation to albumin. The conjugates inhibited the 
replication of Ectromelia virus in these cells, whereas 
free drugs were ineffective [3]. 
It was shown that some glycoproteins, uch as 
fetuin, after removal of sialic acid are selectively 
taken up by hepatocytes where they are digested in 
lysosomes [4-61. In the experiments reported here 
trifluorothymidine (F3T) was coupled to asialofetuin 
(AF) in order to concentrate the drug into hepato- 
cytes, as a possible approach to the treatment of 
hepatitis caused by deoxyriboviruses. 
2. Materials and methods 
2.1. F,T-AFconjugate 
Fetuin was desialylated by neuraminidase accord- 
ing to [7]. The conjugate of FsT with AF (F,T-AF) 
was obtained by coupling the hydroxysuccinimidester 
of trifluorothymidine glutarate to AF. To a solution 
of F3T (500 mg, 1.69 mmol) in 20 ml pyridine, 
glutaric anhydride (245 mg, 2.15 mmol) was gradually 
added (2 h) with stirring at 80°C. After keeping at the 
same temperature overnight, he solvent was evap- 
orated under vacuum; the residue was dissolved in 
1.5% aqueous acetic acid and chromatographed ona 
Sephadex LH20 column (200 X 3 cm) with the same 
solvent. Fractions 73-86 (each fraction 20 ml) con- 
tained FsT (250 mg); fractions 87-104 contained 
trifluorothymidine glutarate and were lyophilized 
(180 mg). Trifluorothymidine glutarate most 
probably was a binary mixture of 5’-glutarate (main 
product) and 3’,5’-diglutarate which migrated in high- 
voltage paper electrophoresis (pH 6.5) faster than the 
monoester. The ultraviolet spectrum of the glutarates 
was identical with that of trifluorothymidine (max. 
260 nm). The mixture was dissolved in dimethyl- 
formamide (5 ml); then N-hydroxysuccinimide 
(79 mg, 0.69 mmol) and dicyclohexylcarbodiimide 
(142 mg, 0.69 mmol) were gradually added at 4°C. 
After 72 h at the same temperature the precipitate 
was filtered and the solution was added over 4 h to 
a solution of 200 mg AF in 20 ml water at pH 6-7 
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and 4°C. After stirring overnight at 4”C, the solution 
was dialyzed thoroughly at the same temperature against 
water and lyophilized. The residue was dissolved in 
10 ml of a 0.05% ammonium bicarbonate solution, 
chromatographed through a Sephadex G-75 column 
(100 X 2 cm) and eluted with the same solvent. 
Fractions 9-24 (each fraction 5 ml) were lyophilized 
yielding 105 mg FsT-AF. The molar ratio of F3T : 
AF in the conjugate was calculated spectrophoto- 
metrically and was found to be 8 (50 pg FBT in 1 mg 
F,T-AF). 
2.2. Blood clearance of labeled AF 
AF was labeled (1.7 X lo6 dpm/mg) with [14C]- 
formaldehyde according to [8]. Mice were injected 
i.v. with [14C]AF at 2 ccg/g body wt. Each compound 
to be tested for competition was administered i.v. at 
60 fig/g body wt. At the indicated times mice were 
bled from the retro-orbital plexus and the radio- 
activity of plasma was determined. 
2.3. DNA synthesis in liver and bone marrow of 
Ectromelia virus-infected mice 
In each experiment 15 Swiss female mice (28-3 1 g) 
were injected i.v. with Ectromelia virus at the multi- 
plicity of 2.0 X 10’ p.f.u./g body wt corresponding 
to 300.times the LDso. Ectromelia virus (Hampstead 
mouse strain) was grown in L-929 cells and purified 
according to [9,10]. After 44 h infection mice were 
divided in 3 groups, each of 5 animals. Animals of 
groups 1 and 2 were injected i.v. with free F3T or 
with FJT-AF, both administered in saline in 10 pi/g 
body wt. Animals of group 3 were injected with 
saline only and used as controls. After 1 h, all mice 
were injected i.p. with deoxy-[5-3H]cytidine (spec. 
act. 20 Ci/mmol) at 60 @i / mouse. After 1 h deoxy- 
[5-3H]cytidine administration, mice were killed and 
liver and bone marrow from femurs were rapidly 
removed. DNA was extracted as in [l 11, its radio- 
activity was cgunted and its concentration was 
measured according to [ 121. 
3. Results and discussion 
Conjugation with F3T did not change the capacity 
of AF to interact with the specific receptors on the 
surface of hepatocytes. Indeed, the clearance of 
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14C-labelled AF from the blood of mice was com- 
petitively inhibited at the same xtent by F3T-AF or 
by an equal amount of non-conjugated AF. Non- 
desialylated fetuin and heat-denatured albumin, 
which do not compete with AF for the surface recep- 
tors of hepatocytes [4] did not affect the plasma 
clearance of labelled AF (fig.1). 
Hepatitis caused by Ectromelia virus in mice was 
chosen as experimental model of hepatocyte infec- 
tion by deoxyriboviruses. Ectromelia virus is a pox- 
virus which, when injected intravenously into mice, is 
ingested mainly by Kupffer cells in the liver where 
it carries out the first cycle of replication. After 
lo-12 h inoculation it starts to infect hepatocytes; 
thereafter the infected foci spread to surrounding 
E 
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Fig. 1. Blood clearance of [ 14C]AF alone (0) or in the pres- 
ence of cold, non-conjugated AF (o), F,T-AF (4, non- 
desialylated fetuin (A) and heat-denatured rabbit serum 
albumin (0). Details are given in section 2.2. Each point 
represents the mean value of results from 2 animals. 
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parenchymal cells, ultimately causing liver necrosis 
[13,14] (and our unpublished electron microscope 
observations). We observed that DNA synthesis, 
which is negligible both in normal iver and during the 
phase of Ectromelia virus replication in Kupffer cells, 
increases several times after 14-50 h virus inocula- 
tion, when the Infection spreads to hepatocytes. 
Since poxviruses inhibit cell DNA synthesis during 
infection [ 151 this increased DNA synthesis in hepa- 
tocytes must be ascribed to virus DNA replication. 
Under our experimental conditions liver necrosis was 
observed beginning after 65-70 h virus inoculation. 
FsT and FsT-AF were injected in infected mice 
during the phase of active virus replication in hepa- 
tocytes and their effect was determined on virus DNA 
synthesis in liver and on cell DNA synthesis in bone 
marrow. As shown in fig.2, free FsT and FsT coupled 
to AF inhibited DNA synthesis in liver and in bone 
marrow. FsT coupled to AF caused, at the 3 lower 
doses, an inhibition of DNA synthesis in liver >3- 
times higher than that produced by the free drug. On 
the contrary, the percentage of inhibition in bone 
marrow was similar when FsT was administered 
either coupled to AF or as a free drug. These results 
indicate that, after injection of the conjugate, FsT 
was concentrated in active form into hepatocytes. 
Three possibilities can be considered to explain 
the inhibition of DNA synthesis caused by the con- 
jugate in bone marrow. 
(1) 
(2) 
(3) 
Bone marrow cells take up the conjugate. This 
possibility is unlikely because the experiments 
of competition (fig.1) indicated that conjugated 
AF behaved like native AF which is taken up 
almost exclusively (>90%) by the liver [ 161. 
The bond linking FsT to glutarate in the con- 
jugate is split in the blood. 
Part of FsT released from the conjugate into 
hepatocytes escapes from these cells into the 
blood and reaches bone marrow cells as a free 
drug. 
To resolve these points we determined the effect of 
the conjugate on bone marrow DNA synthesis in 
mice with hepatic necrosis caused by Ectromelia virus 
or by cw-amanitin [ 171. In these animals the uptake of 
AF by the liver is hindered, as demonstrated by a 
delayed plasma clearance (our unpublished ata). 
Table 1 shows that DNA synthesis in bone marrow 
was not inhibited by FsT-AF in mice with hepatic 
necrosis, whereas free FsT produced a 50% inhibition 
as compared to normal controls. These results rule 
out the first two possibilities and consequently make 
it very likely that the inhibition of DNA synthesis in 
bone marrow of normal and infected mice is due to 
free FsT escaped from hepatocytes after these cells 
have taken up the conjugate. This conclusion suggests 
that the ratio of inhibition of DNA synthesis in liver 
to that in bone marrow could be further increased 
by conjugating to AF a drug with a lower ability than 
FsT to cross the external membrane of cells. 
r, 
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Fig.2 Inhibition of DNA synthesis by free EpT (0) or F,T 
coupled to AF (0) in liver and bone marrow of Ectromelia 
virus infected mice. Experimental details are given in sec- 
tion 2.3. For each dose of free and conjugated F,T 2 or 3 
experiments were performed. Results (dpm/mg DNA) were 
statistically evaluated by means of Student’s t test. The dif- 
ference between deoxy-[5-3H]cytidine incorporation into 
liver DNA in mice treated with free F,T or with F,T-AF 
was statistically significant for F,T doses of 0.07, 0.15 and 
0.3 rg/g body wt (P<O.OOl, 0.05 and 0.001 for the 3 doses, 
respectively). The difference was not statistically significant 
(P>O.OS) for the F,T dose of 1.2 @g/g body wt. The dif- 
ference was not statistically significant for all the F,T doses 
in bone marrow. 
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Table f 
Effect of F,T-AF and F,T on deoxy-~5-~~]cyti~me incorporation in bone marrow of normal mice 
and of mice with liver necrosis 
Expt Compounds dpm/mg DNA 
1 Normal mice (5)s 
Normal mice (5) 
2 Normal mice (5) 
Normal mice (5) 
3 Normal mice (8) 
Mice with hepatic necrosis 
by E&omelia virus (7) 
4 Normal mice (5) 
Mice with hepatic necrosis 
by aramanitin (7) 
5 Normal mice (5) 
Mice with hepatic necrosis 
by cy-amanitin (S) 
6 Normal mice (5) 
Mice with hepatic necrosis 
by cu-amanitin (5) 
F,T-AF 
F,T-AF 
F,T-AF 
- 
F,T-AF 
- 
F ,T-AF 
F,T 
261436 1: 76 182 
153 228 1: 18 0.56 (4Ub P<O.O2 
369 721 f 56 586 
203 175 f 39 134 (45) P<O.OOl 
29038ls56530 
301983 f 62 928 
201680 f 31242 
203708~66110 
264 623 k 57 830 
246 412 I 72 616 (7) NS’ 
263849k28816 
127 846 f 33 734 (51) P<O.OOl 
a Number of mice in each group is shown in parentheses 
b Number in parentheses i the percentage of inhibition 
c No~ign~c~t 
fn expt 1-5, F,T-AF was injected i.v. at 6 ngfg body wt ~o~e~~~g to 0.3 ng F,T. In expt 6 free 
F,T was injected at the dose of 0.3 g/g body wt. After 1 h animals received 5~1 i-p* isijejecticm of 60 #i 
deoxy*~~-3~]~~~e and were then processed as in section 2.3. In expt 3, F,T-AF was administered 
to micewhich 80 h earlier had received an i.v. injection of Ectroomelia virus (4.0 X lU* p.f.u./g body wt 
corresponding to 600-times the LD,,). In expt 4-6, F,T-AF or F,T were injected to mice which 
40 h earlier had been injected i.p. with or-amanitht (1.5 pg/g body wt), In the groups of Ectromdiu VW 
or or-amanitin treated animals, bent? marrow was removed only from those mice showing a macroscopic 
liver necrosis which was subsequently confirmed by histologic examination 
Nucleasides with inhibitory activity on DNA syn- 
thesis are commonly employed in antiviral chemo- 
therapy. One of them, adenine arabinoside (ara-A), 
has been recentiy used in the treatment of human 
hepatitis type B. Evidence was given that hepatitis B 
virus replication was ~bited fl8,19] but gastro- 
intestinal symptoms and a slight depression of bone 
marrow functions appeared in treated patients 1181. 
These side effects which lit the use of ara-A in 
hepatitis B infection could be avoided or reduced by 
conjugating the drug to AF, thus causing its selective 
concentration i  hepatocytes. 
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